BioPharmSignal logoBioPharmSignal

Biotech News

LifeVantage Announces Planned Retirement of Steve Fife and CEO Succession Plan

Lifevantage (LFVN)LifevantageCompany update

SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level, today announced that after nine years at LifeVantage, Steve Fife, President, Chief Executive

Related news

LFVNLifevantage2026-08-13 20:30 EST

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2026 Results on August 27, 2026

LFVNLifevantage2026-08-21 12:00 EST

LifeVantage Declares Quarterly Dividend

View all latest news

Lifevantage

Direct-Selling Wellness Company LifeVantage develops and markets nutritional supplements and personal-care products through a network of independent consultants. Nutrigenomics Positioning The company's products are marketed around activation of cellular pathways associated with antioxidant response, metabolism and healthy aging rather...

Recent company news

LFVNLifevantage2026-08-21 12:00 EST

LifeVantage Declares Quarterly Dividend

LFVNLifevantage2026-08-13 20:30 EST

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2026 Results on August 27, 2026

LFVNLifevantage2026-08-11 21:00 EST

LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LFVNLifevantage2026-08-05 20:05 EST

LifeVantage Welcomes Terrence Moorehead as Chief Executive Officer

LFVNLifevantage2026-08-05 20:05 EST

LifeVantage Welcomes Terrence Moorehead as Chief Executive Officer

Stock data

Close
6.69 USD
Market cap
108.75M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States